Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Prat A, Paz-Ares L, Juan M, Felip E, Garralda E, González B, Arance A, Martín-Liberal J, Gavilá J, López-González A, Cejalvo JM, Izarzugaza Y, Amillano K, Corbacho JG, Saura C, Racca F, Hierro C, Sanfeliu E, Gonzalez X, Canes J, Villacampa G, Salvador F, Pascual T, Mesía R, Cervantes A, Tabernero J. Prat A, et al. Future Oncol. 2022 Oct 6. doi: 10.2217/fon-2022-0660. Online ahead of print. Future Oncol. 2022. PMID: 36200668 Review.
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Adamo B, Bellet M, Paré L, Pascual T, Vidal M, Pérez Fidalgo JA, Blanch S, Martinez N, Murillo L, Gómez-Pardo P, López-González A, Amillano K, Canes J, Galván P, González-Farré B, González X, Villagrasa P, Ciruelos E, Prat A. Adamo B, et al. Breast Cancer Res. 2019 Sep 18;21(1):108. doi: 10.1186/s13058-019-1195-z. Breast Cancer Res. 2019. PMID: 31533777 Free PMC article. Clinical Trial.
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
Manso L, Moreno Antón F, Izarzugaza Perón Y, Delgado Mingorance JI, Borrega García P, Echarri González MJ, Martínez-Jañez N, López-González A, Olier Garate C, Ballesteros García A, Chacón López-Muñíz I, Ciruelos Gil E, García-Sáenz JA, Paz-Ares L. Manso L, et al. Breast J. 2019 Mar;25(2):219-225. doi: 10.1111/tbj.13199. Epub 2019 Feb 8. Breast J. 2019. PMID: 30734437 Clinical Trial.
Experience with eribulin in HR+/HER2- metastatic breast cancer, including a male.
Mar Muñoz Sánchez MD, Carmen Soriano Rodríguez MD, Molina Garrido MJ, López-González A, García-Palomo A, López-González L, Plata Fernández MY, Caro NL, Rovira PS. Mar Muñoz Sánchez MD, et al. Future Oncol. 2018 Mar;14(7s):5-12. doi: 10.2217/fon-2017-0355. Future Oncol. 2018. PMID: 29611755
Relationship between Aldehyde Dehydrogenase, PD-L1 and Tumor-Infiltrating Lymphocytes with Pathologic Response and Survival in Breast Cancer.
López Flores M, Honrado Franco E, Sánchez Cousido LF, Minguito-Carazo C, Sanz Guadarrama O, López González L, Vallejo Pascual ME, Molina de la Torre AJ, García Palomo A, López González A. López Flores M, et al. Cancers (Basel). 2022 Sep 11;14(18):4418. doi: 10.3390/cancers14184418. Cancers (Basel). 2022. PMID: 36139578 Free PMC article.
EGFR-mutated advanced lung cancer. Data from a single institution, the Hospital of Leon, in Spain.
Delgado Sillero I, Lopetegui Lia N, Sánchez Cousido LF, Rojas Piedra M, Távara Silva B, Garrido Onecha ML, Medina Valdivieso S, Alonso Horcajo N, Díez Tascón C, López González A, Castañón López C, Pedraza Lorenzo M, García Palomo A, Martín V, Diz Tain P. Delgado Sillero I, et al. J Oncol Pharm Pract. 2023 Jun;29(4):854-860. doi: 10.1177/10781552221085253. Epub 2022 Mar 21. J Oncol Pharm Pract. 2023. PMID: 35306915
Fatty acid intake and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain).
Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Gracia-Lavedan E, Pérez-Gómez B, Oribe M, Martín V, Guevara M, Rodríguez-Cundín P, Fernández-Tardón G, Marcos-Gragera R, Molina-Barceló A, Díaz-Santos M, Castaño-Vinyals G, Aragonés N, López-Gonzalez A, Amiano P, Castilla J, Alonso-Molero J, Kogevinas M, Pollán M, Llorca J. Dierssen-Sotos T, et al. Eur J Nutr. 2020 Apr;59(3):1171-1179. doi: 10.1007/s00394-019-01977-8. Epub 2019 May 8. Eur J Nutr. 2020. PMID: 31069457
Surveillance of resected non-small cell lung cancer.
López-González A, Ibeas Millán P, Cantos B, Provencio M. López-González A, et al. Clin Transl Oncol. 2012 Oct;14(10):721-5. doi: 10.1007/s12094-012-0841-z. Epub 2012 Jul 21. Clin Transl Oncol. 2012. PMID: 22855136 Review.
False-positive interpretations in respiratory cytopathology.
López-González A, Sánchez A, Yebra M, Provencio M. López-González A, et al. Clin Rheumatol. 2013 Mar;32 Suppl 1:S15-7. doi: 10.1007/s10067-009-1281-1. Epub 2009 Sep 26. Clin Rheumatol. 2013. PMID: 19784711 No abstract available.
165 results